U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07336862) titled 'Bariatric Surgery Combined With GLP-1 Receptor Agonists Study' on Sept. 29, 2025.
Brief Summary: Obese patients exhibit considerable heterogeneity and complex comorbidities, making long-term effective management challenging with single therapies. While bariatric surgery remains the most effective weight-loss intervention, postoperative weight regain and metabolic deterioration require attention. GLP-1 RAs offer distinct advantages for weight and metabolic improvement, and their combined application with surgery may yield synergistic benefits. This study investigates the efficacy and safety of bariatric surgery combined with GLP-1 re...